Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Organon develops potent inhibitor of alpha-glucosidase I

June 7, 1996

Anika Research seeks European marketing approval for Orthovisc

June 7, 1996

Knoll describes antiarthritic and immunomodulator derivatives

June 7, 1996

LJP-394 marketing agreement between La Jolla Pharma and Leo Denmark discontinued

May 31, 1996

Zeneca claims prostaglandin E antagonists

May 31, 1996

Merck Frosst Canada reveals cyclooxygenase type 2 (COX-2) inhibitors

May 31, 1996

Di-tert-butylphenol compounds from Proctor & Gamble

May 31, 1996

Update on ConXn clinical progress

May 24, 1996

COX-2 inhibitors in clinical trials at Merck & Co.

May 24, 1996

COX-2 inhibitor selected for further study at Searle

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...